Filmmakers offers ‘Food’ for thought
Boston Globe - 6/21/2009. By Devra First – Where does our food come from? This is the question posed by producer and director Robert Kenner in his film “Food, Inc.’’ The answer is overwhelmingly “not farms.’’ Kenner creates a portrait of a food system controlled by corporate interests that put profit before people’s health. Putting a face to this are individuals such as food-safety advocate Barbara Kowalcyk, whose son died after eating E. coli-tainted meat; Moe Parr, a seed cleaner who was sued by Monsanto; Joel Salatin of Polyface Farm, where animals are fed grass and live in species-appropriate habitats; and food journalists Michael Pollan and film coproducer Eric Schlosser. |
|
Urban poultry farms ruffle some feathers
Boston Globe - 6/21/2009.By P.J. Huffstutter, LA Times – MADISON, Wis. - Jen Lynch and her family live in the heart of the city but roll out of bed to the sound of chickens clucking. Their day starts with cleaning coops, scooping out feed, and hunting for eggs for morning omelets. Eight families in a three-block radius and an estimated 150 families citywide do the same. “It’s our slice of rural life, minus the barns,’’ said Jen Lynch, 35, as Flicka the chicken pecked at her backyard lawn. |
|
Food safety in the 21st century
Grist - 6/21/2009.By Dave Murphy – Just when America thought it was safe to go back into the grocery store, another food outbreak wakes us up to the fact that there is something seriously wrong with its food safety system. This time it’s Nestle Toll House cookie dough with E.coli, a treat that nearly every kid in America reaches for a few times a month during the summer. This is yet another reminder why it’s important to get the new food safety legislation, currently winding its way through Congress, right. |
|
EU to examine national opt-outs for GM crop growing
Common Dreams - 6/21/2009.By Jeremy Smith – BRUSSELS - Eleven European Union countries will call next week for the right to opt-outs for growing genetically modified (GM) crops, to cut through complex EU decision-making and end years of stalemate on biotech policy. |
|